Crude Oil Plummets! Iran Takes a Hard Line, Pentagon Makes New Moves! Q1 Earnings Preview

Special Topic: The Current Mid-Term Low Point in A-Share Market, Deep Adjustments Present Good Opportunities for Positioning

Trading stocks? Check out Golden Kylin Analyst Reports—authoritative, professional, timely, comprehensive—helping you discover potential thematic opportunities!

First batch of Q1 earnings forecasts released!

U.S. stocks surge, oil prices plummet!

On March 23, international oil prices suddenly dropped sharply. NYMEX WTI crude oil and ICE Brent both fell nearly 10%.

The three major U.S. stock indices performed strongly, with the Dow Jones up 1.38%, the Nasdaq Composite up 1.38%; the S&P 500 rose 1.15%, the largest single-day gain since February 6.

A50 stock index futures also rose sharply, with an increase of over 1% as of the latest data.

According to CCTV News, on the 23rd, U.S. President Trump posted on social media platform “Real Social” that “the U.S. and Iran have had very good and productive talks over the past two days.”

Trump said he has instructed a five-day pause on all military strikes against Iranian power plants and energy infrastructure, provided ongoing meetings and discussions are successful.

Later, Trump also stated that the U.S. is negotiating with Iran to see if a broader agreement can be reached. He said Iran still has one last chance to end its threats against the U.S… The world will soon become safer.

However, this message was immediately denied by Iran.

According to CCTV News, regarding Trump’s statement that “the U.S. and Iran have had very good and effective talks,” Iran’s Fars News Agency quoted sources as saying, “Iran and the U.S. have not communicated directly, nor through mediators.”

Iranian Parliament Speaker Ali Larijani also posted on social media denying any dialogue with the U.S… Iranian media, citing sources, said that the claim of a meeting between Iran’s Parliament Speaker Larijani and the U.S. is completely false, and one purpose of fabricating this false news is to create conditions for assassinating Larijani. The sources also said that the false news aims to slander Larijani, cause division within Iran, and incite public sentiment.

Israel’s Prime Minister’s Office has not issued any statement regarding Trump’s remarks. In a video speech on the 23rd, Israeli Prime Minister Netanyahu said he had a phone call with U.S. President Trump earlier, and Israel will continue airstrikes against Iran and Lebanon.

Meanwhile, regarding the seizure of Halek Island, Xinhua News Agency reported on March 24 that the Pentagon is considering deploying a combat brigade of about 3,000 troops from the 82nd Airborne Division to support military operations against Iran, possibly to seize Iran’s oil export hub, Halek Island.

The report quoted U.S. officials as saying that the U.S. military is also considering another plan to seize Halek Island, led by approximately 2,500 Marines from the 31st Marine Expeditionary Unit en route to the Middle East. After the initial attack on the island, the combat brigade from the 82nd Airborne could be used for replacement and rotation. The report stated that the Pentagon and U.S. Central Command have not issued any orders regarding the island seizure.

First batch of Q1 earnings forecasts released!

On the evening of March 23, Fuxiang Pharmaceutical announced its Q1 2026 performance forecast. The announcement shows that Fuxiang Pharmaceutical achieved a net profit attributable to shareholders of 52 million to 75 million yuan in Q1, a year-on-year increase of 2222.67% to 3250.01%.

Fuxiang Pharmaceutical stated that during the reporting period, benefiting from the sustained improvement in the new energy industry, steady growth in the power battery market demand, and rapid explosion of energy storage battery demand, upstream lithium battery materials demand continued to rise. The company’s lithium battery electrolyte additive business performed well, with core products like VC and FEC increasing in both volume and price, significantly boosting the company’s performance year-over-year.

According to Securities Times Data Treasure, as of March 24, ten A-share listed companies have released Q1 2026 performance forecasts. Among them, eight are expected to increase or slightly increase, one is expected to turn profitable, and one to continue loss. Based on median estimates, Haiguang Information, Ailisi, and Wanbangde have net profits exceeding 100 million yuan, at 670 million, 590 million, and 165 million yuan respectively.

Haiguang Information expects to achieve revenue of 3.91 to 4.22 billion yuan in Q1 2026, a year-on-year increase of 62.91% to 75.82%; net profit attributable to shareholders of 620 million to 720 million yuan, up 22.56% to 42.32%. Haiguang Information stated that with the rising demand for domestic high-end chips driven by AI industry needs, the market demand continues to grow. The company has increased R&D investment, optimized product performance, and accelerated product iteration, expanding its high-end processor market share and achieving significant revenue growth and sustained performance improvement.

Ailisi expects to achieve revenue of 1.55 billion yuan in Q1 2026, up 41.12% year-on-year; net profit attributable to shareholders of 590 million yuan, up 43.73%. Ailisi said that supported by national medical insurance policies, sales revenue and promotional service income of commercialized products continued to grow, driving ongoing business performance improvement.

From the perspective of net profit changes, Fuxiang Pharmaceutical, Wanbangde, Fuliwang, Oulide, and Ubox expect their Q1 net profits to double year-on-year, with increases of 2736.34%, 985.4%, 219.33%, 204.69%, and 102.82%, respectively. Weili expects to turn a profit in Q1.

Wanbangde expects to achieve a net profit attributable to shareholders of 165 million yuan in Q1 2026, a year-on-year increase of 985.4%. The performance growth is mainly due to the initial success of the company’s strategic shift from generic drugs to innovative drugs, with positive progress in business expansion during the reporting period, creating new growth points, and increased R&D efforts.

Weili expects to realize a net profit attributable to shareholders of 4 to 6 million yuan in Q1 2026, turning from loss to profit. Weili stated that in Q1, the company’s business structure continued to optimize, overall gross profit margin increased. Through prior structural adjustments, personnel optimization, and cost control measures, the company further reduced expenses.

【Live Broadcast Preview】